Psychosocial interventions and medication adherence in bipolar disorder.
Recent research has indicated that psychosocial interventions can have a valuable role in reducing the substantial psychosocial disability associated with bipolar disorder. Randomized controlled trials of these interventions indicate that improvements are seen in symptoms, psychosocial functioning, and treatment adherence. These interventions, systematically presented in the form of standardized treatment manuals, vary in format, duration, and theoretical basis. All are meant to augment pharmacotherapy, which represents the standard of treatment in the field. Modalities that have gathered the most empirical support include cognitive-behavioral therapy, family-focused therapy, interpersonal and social rhythms therapy, and psychoeducation. The enhancement of adherence to pharmacotherapy is a common therapeutic target, due to the association of nonadherence with higher relapse rates, hospitalization, and health care costs among people with bipolar disorder. Given the complexity of nonadherence behavior, multicomponent interventions are often required. In this review, we provide an overview of the rationale, evidence base, and major psychotherapeutic approaches in bipolar disorder, focusing on the assessment and enhancement of medication adherence.
Depp
Colin A
CA
Sam and Rose Stein Institute for Research on Aging, Department of Psychiatry, University of California, San Gilman Drive, 0664 La Jolla, CA 92093-0664, USA. cdepp@ucsd.edu
Moore
David J
DJ
Patterson
Thomas L
TL
Lebowitz
Barry D
BD
Jeste
Dilip V
DV
D018692:Antimanic Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000628:therapy*; D015928:Cognitive Behavioral Therapy / Q000379:methods / Q000639:trends; D006801:Humans; D010349:Patient Compliance / Q000523:psychology / Q000706:statistics & numerical data; D011613:Psychotherapy / Q000379:methods* / Q000639:trends*; D012944:Social Support
D018692:Antimanic Agents